Migraine Market Size, Growth, Trends [2022-2029] | Global Industry Share, Key Players, Demand, Type & Application, Market Dynamics, Sales, Revenue, Price and Gross Margin, Supply Chain and Forecast Research | Market Reports World
April 25, 2022 05:17 ET
|
Market Reports World
Pune, April 25, 2022 (GLOBE NEWSWIRE) -- The global Migraine Market 2022 research report provides an in-depth analysis of market size, share, growth, trends and forecast. The Migraine Market...
New Accuracy in Media Award For Depiction of Migraine and Headache Disorders in Film and TV
March 08, 2022 12:53 ET
|
National Headache Foundation
Chicago, IL, March 08, 2022 (GLOBE NEWSWIRE) -- The National Headache Foundation (NHF) announced a new annual award, the Ellen Aubry Memorial Award, to recognize the accurate depiction of headache...
NHF Calls on Congress and Federal Agencies to Conduct Oversight Of Current Care Models for Migraine Patients
February 03, 2022 14:44 ET
|
National Headache Foundation
Chicago, IL, Feb. 03, 2022 (GLOBE NEWSWIRE) -- Tom Dabertin, Chief Executive Officer/Executive Director of the National Headache Foundation (NHF) is calling on members of Congress and regulatory...
CenExel Clinical Research Acquires California Neuroscience Research
January 10, 2022 13:10 ET
|
CenExel Clinical Research
Salt Lake City, Utah, Jan. 10, 2022 (GLOBE NEWSWIRE) -- CenExel Clinical Research, Inc., (“CenExel”) announces the acquisition of California Neuroscience Research (“CenExel CNR”), a clinical...
Chronic Pain Market to Surpass US$ 108,814 Million by 2028, Says Coherent Market Insights (CMI)
November 17, 2021 08:40 ET
|
CMI
SEATTLE, Nov. 17, 2021 (GLOBE NEWSWIRE) -- According to Coherent Market Insights, the global chronic pain market is estimated to be valued at US$ 64,068 million in 2020 and is expected to exhibit a...
Axsome Therapeutics Reports Third Quarter 2021 Financial Results and Provides Business Update
November 08, 2021 07:00 ET
|
Axsome Therapeutics, Inc.
Company to host conference call today at 8:00 AM Eastern NEW YORK, Nov. 08, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies...
electroCore Announces Third Quarter 2021 Financial Results
November 04, 2021 16:01 ET
|
electroCore, Inc.
Third quarter 2021 revenue grew 17% sequentially and 38% over third quarter 2020 Company to host a conference call and webcast today, November 4, 2021 at 4:30 pm ET ROCKAWAY, N.J., Nov. 04, 2021 ...
Singer-Songwriter Living With Migraine to Perform Song, "Not All in our Heads"
September 15, 2021 15:39 ET
|
National Headache Foundation
Chicago, IL, Sept. 15, 2021 (GLOBE NEWSWIRE) -- Country music singer-songwriter Allie Sealey will perform at the National Headache Foundation (NHF) gala on Oct. 2 at the Langham Hotel in Chicago,...
Axsome Therapeutics Announces FDA Acceptance of New Drug Application for AXS-07 for the Acute Treatment of Migraine
September 14, 2021 07:00 ET
|
Axsome Therapeutics, Inc.
NEW YORK, Sept. 14, 2021 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing novel therapies for the management of central nervous system (CNS)...
Shades for Migraine Partners with Rising Influencers to Empower People with Migraine
May 25, 2021 09:03 ET
|
Association of Migraine Disorders
Rhode Island, May 25, 2021 (GLOBE NEWSWIRE) -- Providence, R.I. (May 25, 2021) – Global awareness campaign, Shades for Migraine®, teams up with two rising social media influencers, YouTuber,...